Cancer diagnoses and age-standardised incidence rates for all types of cancer by age and sex including breast, prostate, lung and colorectal cancer.

This publication reports on newly diagnosed cancers registered in England in addition to cancer deaths registered in England during 2020. It includes this summary report showing key findings, spreadsheet tables with more detailed estimates, and a methodology document.

Breast cancer is a disease which affects much more women than men. In England in 2022, over 50 thousand new cases of breast cancer were registered among women. The most affected age group was women aged 65 to 69 years of age with over 6.3 thousand cases reported.

In 2021, 81.5 males and 66.1 females per 100,000 population in England were registered as newly diagnosed with malignant neoplasm of trachea, bronchus and lung. Over the analyzed years, the rate of newly diagnosed cases for male individuals has seen a decrease trend. Conversely, the rate of newly diagnosed cases for females has seen a steady increase over the years. This statistic shows the rate of newly diagnosed cases of lung cancer per 100,000 population in England from 1995 to 2021, by gender.

This statistic shows the amount of registrations of newly diagnosed cases of stomach cancer in England in 2022, by age group. With a total of 447 cases in 2022, the age group most affected by stomach cancer in terms of the number of cases was men aged 75 to 79 years. It should be noted that the number of people in England in each age group varies and is therefore not necessarily a reflection of susceptibility to this cancer.

One-year and five-year net survival for adults (15-99) in England diagnosed with one of 29 common cancers, by age and sex.

This statistic shows the amount of registrations of newly diagnosed cases of lung cancer in England in 2021, by age group and gender. In this year, almost four thousand cases were reported among men aged 70 to 74 years. It should be noted that the number of people in England in each age group varies and is therefore not necessarily a reflection of susceptibility to lung cancer.

This statistic shows the number of registrations of newly diagnosed cases of ovarian cancer in England in 2022, by age group. The most affected age group was among 75 to 79 year olds, with 908 cases reported in 2022.

This statistic shows the rate of registrations of newly diagnosed cases of lung cancer per 100,000 population in England in 2020, by region and gender. With a rate of 100.8 newly diagnosed males with lung cancer and 90.8 females per 100,000 population in 2020, the region most affected by lung cancer was the North East.

Presents information on the number of newly diagnosed cases of cancer (incidence) and the age-standardised incidence rates for England. This publication has been discontinued and the data are now included within Cancer Statistics Registrations, England (Series MB1) so that all cancer registration data can be found in one place. The last volume to be published was Cancer Registrations in England - 2010 Source agency: Office for National Statistics Designation: National Statistics Language: English Alternative title: Cancer Registrations in England

Information on the waiting times of patients with suspected cancer and those subsequently diagnosed with cancer

Source agency: NHS England

Designation: National Statistics

Language: English

Alternative title: Statistics on Waiting Times for Suspected and Diagnosed Cancer Patients Annual Report

The Get Data Out programme from the National Disease Registration Service publishes detailed statistics about small groups of cancer patients in a way that ensures patient anonymity is maintained. The Get Data Out programme currently covers 15 cancer sites. This data release is a corrected re-release of detailed statistics for 2013-2019 treatment data. The correction means that surgery counts are no longer slightly underreported. There are some small changes in group sizes of usually no more than 2%, although this is larger for non-melanoma skin cancers. The 15 cancer sites now covered by Get Data Out are: ‘Bladder, Urethra, Renal Pelvis and Ureter’, ‘Bone cancer’, ‘Brain, meningeal and other primary CNS tumours’, ‘Eye cancer’, ‘Head and neck’, ‘Kaposi sarcoma’, ‘Kidney’, ‘Oesophageal and Stomach’, ‘Ovary, fallopian tube and primary peritoneal carcinomas’, ‘Pancreas’, ‘Prostate’, ‘Sarcoma’, ‘Skin tumours’, ‘Soft tissue and peripheral nerve cancer’, ‘Testicular tumours including post-pubertal teratomas’. Anonymisation standards are designed into the data by aggregation at the outset. Patients diagnosed with a certain type of tumour are divided into many smaller groups, each of which contains approximately 100 patients with the same characteristics. These groups are aimed to be clinically meaningful and differ across cancer sites. For each group of patients, Get Data Out routinely publish statistics about incidence, routes to diagnosis, treatments and survival. All releases and documentation are available on the Get Data Out main technical page. Before using the data, we recommend that you read the guide for first time users. The data is available in an open format for anyone to access and use. We hope that by releasing anonymous detailed data like this we can help researchers, the public and patients themselves discover more about cancer. If you have feedback or any other queries about Get Data Out, please email us at NDRSenquires@nhs.net and mention 'Get Data Out' in your email.

Brings together a large amount of information on cancer incidence, deaths from cancer, prevalence and survival from cancer.

Source agency: Office for National Statistics

Designation: Official Statistics not designated as National Statistics

Language: English

Alternative title: Cancer Trends in England and Wales

This statistic shows the amount of registrations of newly diagnosed cases of cancer in England in 2021, by age group and gender. Men aged 75 to 79 years had the highest number of reported cases as 49,340. It should of course be noted that the number of people in England in each age group varies and is therefore not necessarily a reflection of susceptibility to cancer.

The Welsh Cancer Intelligence & Surveillance Unit (WCISU) is the National Cancer Registry for Wales and its primary role is to record, store and report on all incidence of cancer for the resident population of Wales wherever they are treated. Cancer registration in Wales began almost five decades ago and today’s electronic database which holds records going back to 1972 contains in the region of 686,000 records.

WCISU collects data about occurrences of cancer in Welsh residents via direct or indirect submissions from Welsh Hospitals.

Staging of malignant melanoma (ICD 10 code C43), breast (C50), colorectal (C18-C20) and cervix (C53) started in 2001 since this was when we started receiving pathological information. Staging for all other cancers started in 2010.

Treatment information started in 1995.

Cancer registrations for Breast cancer per 100,000 population. Directly standardised registration rate Source: Regional Cancer Registries, Office for National Statistics (ONS). Publisher: Information Centre (IC) - Clinical and Health Outcomes Knowledge Base Geographies: Local Authority District (LAD), Government Office Region (GOR), National, Strategic Health Authority (SHA) Geographic coverage: England Time coverage: 2004-2006 Type of data: Administrative data

The English Cancer Patient Experience Survey (CPES) is commissioned by NHS England and administered on their behalf by an external survey provider organisation (Quality Health). The survey provides insights into the care experienced by cancer patients across England who were treated as day cases or inpatients. Data from CPES has been linked to cancer registration records recorded by the National Cancer Registration and Analysis Service (the cancer registry in England). Individual responses to Wave 2 of CPES are recorded , alongside characteristics of the patient who has completed the survey.

Wave 2 of the National Cancer Patient Experience Survey is limited to patients discharged from cancer care between 01/09/2011 – 30/11/2011.

Data within the file: --PATIENT_PSEUDO_ID (Project specific Pseudonymised Patient ID) GENDER (coded Male, Female) --QUINTILE2010 (Deprivation quintile [1-5], describing the Income Deprivation Domain where 1= least deprived and 5= most deprived) --FINAL_ROUTE (One of eight Routes to Diagnosis- methodology for the assignment of each route is described in Elliss-Brookes L, McPhail S, Greenslade M, Shelton J, Hiom S, Richards M (2012) Routes to diagnosis for cancer – determining the patient journey using multiple routine data sets. British Journal of Cancer 107: 1220–1226.) --AGE (aggregated in 4 categories: <55, 55-64, 65-74, 75+) --STAGE (stage of the cancer coded as I, II, III, IV, missing) --CANCER_SITE (Cancer sites coded in accordance with ICD 10: C00-C14, C15, C16, C18, C19-C20, C25, C33-C34, C43, C49, C50, C54, C56, C61, C64, C67, C73, C82, C83, C85, C90, C91-C95, D05 and ‘all other ICD-10 codes’

Specific disclosure controls applied: --Gender omitted from the data specification in the following cancer sites: • Female only for C50, D05 and C73 • Male only for C49
--Self-reported ethnicity (from the CPES surveys) aggregated into white British / non-white British / not specified. --Self-reported ethnicity omitted for C49, C64, C73 (replaced as “missing”).